Market Place
Sourcing Support
ENA Respiratory Publishes INNA-051 Studies on Influenza Challenge
18 Dec 2024 //
GLOBENEWSWIRE
ENA Respiratory Announces U.S. DoD Funding Extension
05 Sep 2024 //
GLOBENEWSWIRE
ENA Respiratory Progresses Phase Ib Study Of INNA-051 Powder Formulation
27 Aug 2024 //
GLOBENEWSWIRE
ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral
10 May 2024 //
PHARMABIZ
ENA Respiratory INNA-051 Antiviral Patent Allowed
08 May 2024 //
GLOBENEWSWIRE
ENA Respiratory Gets FDA IND Clearance for INNA-051 Nasal Antiviral
29 Apr 2024 //
GLOBENEWSWIRE
ENA Respiratory Expands Leadership Team & Extends U.S. Dept of Defense Funding
29 Aug 2023 //
GLOBENEWSWIRE
Ena slices data, claims success in phase 2 flu prophylaxis trial
13 Feb 2023 //
FIERCE BIOTECH
J&J program adds Ena`s infectious disease nasal spray to roster
17 May 2022 //
FIERCEPHARMA
ENA Respiratory Selected for BLUE KNIGHT
11 May 2022 //
GLOBENEWSWIRE
First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 Other Ph2 Trials
28 Sep 2021 //
GLOBENEWSWIRE
ENA Respiratory Begins Phase I Study of COVID-19 Preventative Nasal Spray
13 Jul 2021 //
GLOBENEWSWIRE
ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 mn Funding
15 Jun 2021 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.